Literature DB >> 10849488

The effects of isolated lipoproteins and triglyceride, combined oxidized low density lipoprotein (LDL) plus triglyceride, and combined oxidized LDL plus high density lipoprotein on the contractile and relaxation response of rabbit cavernous smooth muscle.

S C Kim1, K K Seo, H W Kim, M Y Lee.   

Abstract

The aim of this study was to investigate the effects of isolated lipoproteins and triglyceride (TG), and the effects of combined oxidized low density lipoprotein (LDL) plus TG and the combined oxidized LDL plus high density lipoprotein (HDL) on the contractility and relaxation response of rabbit cavernous smooth muscle. Cavernous muscle strips from New Zealand White rabbits were studied in organ chambers for isometric tension measurement. The strips were exposed to HDL, LDL, oxidized LDL, TG, combined oxidized LDL plus TG and combined oxidized LDL plus HDL for 30 min. Both HDL and LDL did not affect contraction and relaxation responses of the cavernous muscles. The oxidized LDL did not affect norepinephrine (NE)-induced contractility of the strips, but significantly (p < 0.05) decreased the relaxation response to endothelium-dependent agonist, acetylcholine (Ach). Non-specific NO synthase inhibitor (L-NAME) completely inhibited the relaxation response to Ach, and L-arginine partially improved the diminished relaxation. TG did not significantly change the relaxation responses to Ach, but decreased the contractility of cavernous muscle to NE. Neither the combined oxidized LDL plus TG nor oxidized LDL plus HDL had significant synergistic or detoxication effects on the contractility and relaxation responses. In conclusion, oxidized LDL may have acute toxic effects on the endothelium-dependent, NO-mediated relaxation, but not on the contractility, of rabbit cavernous smooth muscle. TG may decrease contractility of the cavernous muscle. There may be neither synergistic nor detoxication effects on the contractility and relaxation response when TG or HDL is added to the oxidized LDL.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10849488     DOI: 10.1046/j.1365-2605.2000.00007.x

Source DB:  PubMed          Journal:  Int J Androl        ISSN: 0105-6263


  6 in total

1.  Functional, metabolic, and morphologic characteristics of a novel rat model of type 2 diabetes-associated erectile dysfunction.

Authors:  Maarten Albersen; Guiting Lin; Thomas M Fandel; Haiyang Zhang; Xuefeng Qiu; Ching-Shwun Lin; Tom F Lue
Journal:  Urology       Date:  2011-05-31       Impact factor: 2.649

2.  Hypercholesterolemia-induced erectile dysfunction: endothelial nitric oxide synthase (eNOS) uncoupling in the mouse penis by NAD(P)H oxidase.

Authors:  Biljana Musicki; Tongyun Liu; Gwen A Lagoda; Travis D Strong; Sena F Sezen; Justin M Johnson; Arthur L Burnett
Journal:  J Sex Med       Date:  2010-09       Impact factor: 3.802

Review 3.  Basic Science Evidence for the Link Between Erectile Dysfunction and Cardiometabolic Dysfunction.

Authors:  Biljana Musicki; Anthony J Bella; Trinity J Bivalacqua; Kelvin P Davies; Michael E DiSanto; Nestor F Gonzalez-Cadavid; Johanna L Hannan; Noel N Kim; Carol A Podlasek; Christopher J Wingard; Arthur L Burnett
Journal:  J Sex Med       Date:  2015-12-08       Impact factor: 3.802

4.  The herbal formula KH-204 is protective against erectile dysfunction by minimizing oxidative stress and improving lipid profiles in a rat model of erectile dysfunction induced by hypercholesterolaemia.

Authors:  Hoon Jang; Woong Jin Bae; Su Jin Kim; Hyuk Jin Cho; Seung Mo Yuk; Dong Seok Han; Chang Shik Youn; Eun Bi Kwon; Sung Yeoun Hwang; Sae Woong Kim
Journal:  BMC Complement Altern Med       Date:  2017-02-24       Impact factor: 3.659

5.  Biochemical Activity and Hypoglycemic Effects of Rumex obtusifolius L. Seeds Used in Armenian Traditional Medicine.

Authors:  Anush Aghajanyan; Armine Nikoyan; Armen Trchounian
Journal:  Biomed Res Int       Date:  2018-11-07       Impact factor: 3.411

6.  Treatment with CB2 agonist JWH-133 reduces histological features associated with erectile dysfunction in hypercholesterolemic mice.

Authors:  Rodrigo Araujo Fraga-Silva; Fabiana Pereira Costa-Fraga; Fabrizio Montecucco; Younouss Faye; Silvia Quintao Savergnini; Sébastien Lenglet; François Mach; Sabine Steffens; Nikolaos Stergiopulos; Robson Augusto Souza dos Santos; Rafaela Fernandes da Silva
Journal:  Clin Dev Immunol       Date:  2013-11-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.